BiotechTube
Home/Pipeline/Future Molecular POC Tests

Future Molecular POC Tests

Not Specified

Research/Pre-clinicalActive

Key Facts

Indication
Not Specified
Phase
Research/Pre-clinical
Status
Active
Company
Biocrucible

About Biocrucible

Sapphiros is a private, commercial-stage diagnostics company positioned to disrupt global health testing through scalable, low-cost technology platforms. The company has secured significant strategic partnerships, including a major supply agreement with Roche and a development contract with BARDA, validating its manufacturing capability and product pipeline. With a leadership team boasting deep industry experience and a UK-based facility capable of producing five billion units annually, Sapphiros aims to redefine everyday health management by moving testing out of labs and into consumers' hands.

View full company profile

Therapeutic Areas

Infectious DiseasePublic Health

Other Not Specified Drugs

DrugCompanyPhase
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch
Lighthouse Pilot ProductCipheromePilot
Nitric Oxide + Collagen DeliveryJellagenResearch
UndisclosedAutheraPre-clinical
mRNA Therapeutics Platform ApplicationLupagenResearch
PHYRAGOHanda PharmaceuticalsApproved
TASCENSO ODTHanda PharmaceuticalsApproved
AxulinHousey Pharmaceutical Research LaboratoriesCommercial
PBI-04711Phoenix BiotechnologyPre-clinical
Immunology ProgramIgnite BiomedicalDiscovery